Borrelia burgdorferi sensu lato recombinant antigen OspC
| Product description | The recombinant fusion protein contains immunodominant regions of OspC (Outer surface protein C) antigen of different Borrelia species (Borrelia burgdorferi, Borrelia afzelii, Borrelia garinii) |
| Purification methods | Purified by affinity chromatography |
| Buffer composition | 50mM Tris, 5mM Glutathione, pH8.0 |
| Preservative | None |
| Storage | Frozen at -70 ˚C, avoid repeated freeze-thaw cycles |
Borrelia burgdorferi sensu lato recombinant antigen VlsE
| Product description | The recombinant fusion protein contains immunodominant regions of VlsE (Lyme disease variable surface antigen E) antigen of different Borrelia species (Borrelia burgdorferi, Borrelia afzelii, Borrelia garinii) |
| Purification methods | Purified by affinity chromatography |
| Buffer composition | 50mM Tris, 5mM Glutathione, 1mM bME, pH8.0 |
| Preservative | None |
| Storage | Frozen at -70 ˚C, avoid repeated freeze-thaw cycles |
Chlamydia trachomatis recombinant antigen MOMP
| Product description | The recombinant protein is an analogue of Major Outer Membrane protein (MOMP) of Chlamydia trachomatis, expressed and derived from E.coli |
| Purification methods | Purified by affinity chromatography |
| Buffer composition | 50mM Tris, 300mM NaCl, 8M Urea, 250 mM imidazole, pH8.0 |
| Preservative | None |
| Storage | Frozen at -70 ˚C, avoid repeated freeze-thaw cycles |
CMV recombinant antigen p150
| Product description | The recombinant protein contains the CMV P150 (UL32) immunodominant regions, expressed and derived from E.coli in soluble form |
| Purification methods | Purified by affinity chromatography |
| Buffer composition | 50mM Tris, 5mM Glutathione, pH8.0 |
| Preservative | None |
| Storage | Frozen at -70 ˚C, avoid repeated freeze-thaw cycles |
CMV recombinant antigen p28
| Product description | The recombinant protein contains CMV p28 (UL99) immunodominant regions, expressed and derived from E.coli in soluble form |
| Purification methods | Purified by affinity chromatography |
| Buffer composition | 50mM Tris, 20mM Glutathione, pH8.0 |
| Preservative | None |
| Storage | Frozen at -70 ˚C, avoid repeated freeze-thaw cycles |
CMV recombinant antigen p52
| Product description | The recombinant protein contains CMV p28 (UL99) immunodominant regions, expressed and derived from E.coli |
| Purification methods | Extraction of recombinant protein from washed Inclusion Bodies |
| Buffer composition | 50mM Tris, 8M Urea, pH8.0 |
| Preservative | None |
| Storage | Frozen at -70 ˚C, avoid repeated freeze-thaw cycles |
CMV recombinant antigen p65
| Product description | The recombinant protein contains CMV p65 immunodominant regions, expressed and derived from E.coli |
| Preservative | None |
| Storage | Frozen at -70 ˚C, avoid repeated freeze-thaw cycles |
EBV recombinant antigen EBNA1
| Product description | The recombinant protein contains EBV nuclear antigen immunodominant regions, expressed and derived from E.coli |
| Purification methods | Purified by affinity chromatography |
| Buffer composition | 50mM Tris-HCl, 500mM NaCl, 8M Urea, 250mM imidazole, pH8.0 |
| Preservative | None |
| Storage | Frozen at -70 ˚C, avoid repeated freeze-thaw cycles |
EBV recombinant antigen VCA р18
| Product description | The recombinant protein is an analogue of EBV p18 capsid antigen, expressed and derived from E.coli, affinity purified |
| Purification methods | Purified by affinity chromatography |
| Buffer composition | 50mM Tris-HCl, 500mM NaCl, 8M Urea, 250mM imidazole, pH8.0 |
| Preservative | None |
| Storage | Frozen at -70 ˚C, avoid repeated freeze-thaw cycles |
HBV recombinant antigen Hbcore HBV
| Product description | The recombinant protein contains the HCV core immunodominant regions, expressed and derived from E.coli |
| Purification methods | Purified by affinity chromatography |
| Buffer composition | 50mM Tris-HCl, 100mM NaCl, 3M Urea, 300mM imidazole, pH8.0, 50% glycerol |
| Preservative | None |
| Storage | Frozen at -70 ˚C, avoid repeated freeze-thaw cycles |
HCV recombinant antigen CNgst
| Product description | The mosaic recombinant protein contains immunodominant regions of core, NS3, NS4 antigens of Hepatitis C virus |
| Purification methods | Extraction of recombinant protein from washed Inclusion Bodies |
| Buffer composition | 0.02M Tris, 0.01M EDTA, 6MUrea, pH8.0 |
| Preservative | None |
| Storage | Frozen at -70 ˚C, avoid repeated freeze-thaw cycles |
HCV recombinant antigen HCcore
| Product description | The recombinant protein contains the HCV core immunodominant regions, expressed and derived from E.coli |
| Purification methods | Purified by affinity chromatography |
| Buffer composition | 20mM Tris-HCl, 500mM NaCl, 8M Urea, 250mM imidazole, pH8.0 |
| Preservative | None |
| Storage | Frozen at -70 ˚C, avoid repeated freeze-thaw cycles |
HCV recombinant antigen NS3 11
| Product description | The recombinant protein contains HCV NS3 immunodominant regions, expressed and derived from E. coli in soluble form |
| Purification methods | Purified by affinity chromatography |
| Buffer composition | 50mM Tris, 5mM Glutathione, pH8.0 |
| Preservative | None |
| Storage | Frozen at -70 ˚C, avoid repeated freeze-thaw cycles |
HCV recombinant antigen NS3 13
| Product description | The recombinant protein contains HCV NS3 immunodominant regions, expressed and derived from E. coli |
| Purification methods | Purified by affinity chromatography |
| Buffer composition | 50mM Tris, 5mM Glutathione, pH8.0 |
| Preservative | None |
| Storage | Frozen at -70 ˚C, avoid repeated freeze-thaw cycles |
HCV recombinant antigen NS3 1a
| Product description | The recombinant protein contains HCV genotype-1a NS3 immunodominant regions, expressed and derived from E.coli, affinity purified |
| Purification methods | Purified by affinity chromatography |
| Preservative | None |
| Storage | Frozen at -70 ˚C, avoid repeated freeze-thaw cycles |
HCV recombinant antigen NS3 1b
| Product description | The recombinant protein contains HCV genotype-1b NS3 immunodominant regions, expressed and derived from E.coli, affinity purified |
| Purification methods | Purified by affinity chromatography |
| Preservative | None |
| Storage | Frozen at -70 ˚C, avoid repeated freeze-thaw cycles |
HCV recombinant antigen NS3 2b
| Product description | The recombinant protein contains HCV genotype-2b NS3 immunodominant regions, expressed and derived from E.coli, affinity purified |
| Purification methods | Purified by affinity chromatography |
| Preservative | None |
| Storage | Frozen at -70 ˚C, avoid repeated freeze-thaw cycles |
HCV recombinant antigen NS3 3a
| Product description | The recombinant protein contains HCV genotype-3a NS3 immunodominant regions, expressed and derived from E.coli, affinity purified |
| Purification methods | Purified by affinity chromatography |
| Preservative | None |
| Storage | Frozen at -70 ˚C, avoid repeated freeze-thaw cycles |
HCV recombinant antigen NS3 6a
| Product description | The recombinant protein contains HCV genotype-6a NS3 immunodominant regions, expressed and derived from E.coli, affinity purified |
| Purification methods | Purified by affinity chromatography |
| Preservative | None |
| Storage | Frozen at -70 ˚C, avoid repeated freeze-thaw cycles |
HCV recombinant antigen NS4
| Product description | The recombinant protein contains HCV NS4 immunodominant regions, expressed and derived from E.coli in soluble form |
| Purification methods | Purified by affinity chromatography |
| Buffer composition | 50mM Tris-HCl, 5mM Glutathione, 150mM NaCl, pH8.0 |
| Preservative | None |
| Storage | Frozen at -70 ˚C, avoid repeated freeze-thaw cycles |
HCV recombinant antigen NS5
| Product description | The recombinant protein contains HCV NS5 immunodominant regions, expressed and derived from E.coli |
| Purification methods | Purified by affinity chromatography |
| Buffer composition | 50mM Tris, 5mM Glutathione, pH8.0 |
| Preservative | None |
| Storage | Frozen at -70 ˚C, avoid repeated freeze-thaw cycles |
Helicobacter pylori recombinant antigen CagA
| Product description | The recombinant protein contains CagA Helicobacter pylori immunodominant regions, expressed and derived from E.coli |
| Purification methods | Purified by affinity chromatography |
| Buffer composition | 50mM Tris, 20mM Glutathione, pH8.0 |
| Preservative | None |
| Storage | Frozen at -70 ˚C, avoid repeated freeze-thaw cycles |
HHV6 recombinant antigen U90
| Product description | The recombinant protein is an analogue of U90 antigen HHV6, expressed and derived from E.coli, affinity purified |
| Preservative | None |
| Storage | Frozen at -70 ˚C, avoid repeated freeze-thaw cycles |
SARS-CoV-2 recombinant antigen NC
| Product description | The recombinant protein is an analogue of N-capsid protein SARS-CoV-2, expressed and derived from E.coli (His and GST-tagged protein) |
| Purification methods | Purified by affinity chromatography |
| Buffer composition | 10mM Tris, 8M Urea, 100mM NaH2PO4, 250 mM imidazole, pH8.0 |
| Preservative | None |
| Storage | Frozen at -70 ˚C, avoid repeated freeze-thaw cycles |
SARS-CoV-2 recombinant antigen NC
| Product description | The recombinant protein is an analogue of N-capsid protein SARS-CoV-2, expressed and derived from E.coli (His-tagged protein) |
| Purification methods | Purified by affinity chromatography |
| Buffer composition | 10mM Tris, 8M Urea, 100mM NaH2PO4, 250 mM imidazole, pH8.0 |
| Preservative | None |
| Storage | Frozen at -70 ˚C, avoid repeated freeze-thaw cycles |
Treponema pallidum recombinant antigen p17
| Product description | The recombinant protein is an analogue of Treponema pallidum p17 antigen, expressed and derived from E.coli |
| Purification methods | Extraction of recombinant protein from washed Inclusion Bodies |
| Buffer composition | 0.02M Tris, 0.01M EDTA, 8M Urea, pH8.0 |
| Preservative | None |
| Storage | Frozen at -70 ˚C, avoid repeated freeze-thaw cycles |
Treponema pallidum recombinant antigen p41
| Product description | The recombinant protein is an analogue of Treponema pallidum p41 (TmpA) antigen, expressed and derived from E.coli |
| Purification methods | Extraction of recombinant protein from washed Inclusion Bodies |
| Buffer composition | 0.02M Tris, 0.01M EDTA, 8M Urea, pH8.0 |
| Preservative | None |
| Storage | Frozen at -70 ˚C, avoid repeated freeze-thaw cycles |
Treponema pallidum recombinant antigen p47
| Produc description | The recombinant protein is an analogue of Treponema pallidum p47 antigen, expressed and derived from E.coli |
| Purification methods | Extraction of recombinant protein from washed Inclusion Bodies |
| Buffer composition | 0.02M Tris, 0.01M EDTA, 8M Urea, pH8.0 |
| Preservative | None |
| Storage | Frozen at -70 ˚C, avoid repeated freeze-thaw cycles |
Trichomonas vaginalis recombinant antigen AP33
| Product description | The recombinant protein is an analogue of Adhesion protein AP-33 Trichomonas vaginalis, expressed and derived from E.coli in soluble form |
| Purification methods | Purified by affinity chromatography |
| Buffer composition | 10mM Tris-HCl, 100mM NaH2PO4, 8M Urea, 250mM imidazole, pH8.0, 50% glycerol |
| Preservative | None |
| Storage | Frozen at -70 ˚C, avoid repeated freeze-thaw cycles |
Trichomonas vaginalis recombinant antigen α-Actinin
| Product description | The recombinant protein is an analogue of α-Actinin Trichomonas vaginalis, expressed and derived from E.coli in soluble form |
| Purification methods | Purified by affinity chromatography |
| Buffer composition | 50mM NaH2PO4, 300mM NaCl, 250mM imidazole, pH8.0, 50% glycerol |
| Preservative | None |
| Storage | Frozen at -70 ˚C, avoid repeated freeze-thaw cycles |
Ureaplasma spp. recombinant antigen MBA
| Product description | The recombinant protein is an analogue of Multiple Banded Antigen (MBA) Ureaplasma spp., expressed and derived from E.coli |
| Purification methods | Purified by affinity chromatography |
| Preservative | None |
| Storage | Frozen at -70 ˚C, avoid repeated freeze-thaw cycles |